SERACLONE ANTI-K (KEL2)
Report
- Report Number
- 9610824-2010-00004
- Event Type
- Malfunction
- Date Received
- March 18, 2010
- Date of Event
- March 1, 2010
- Report Date
- March 17, 2010
- Manufacturer
- BIOTEST MEDICAL DIAGNOSTICS GMBH
- Product Code
- KSZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
A FIELD SAFETY CORRECTIVE ACTION WAS INITIATED (NOT IN THE U.S.). THE AFFECTED BATCHES ARE NOT ON THE U.S. MARKET, AS THE MENTIONED CATALOG NUMBER IS USED FOR NON-US-PRODUCT ONLY. STN#: 125232.
THE CUSTOMER COMPLAINED THAT THREE PATIENTS WERE TYPED FALSE POSITIVE USING THE BLOOD GROUPING REAGENT SERACLONE ANTI-K (KEL2). THE CUSTOMER SENT US TWO OF THREE PATIENT SAMPLES. THESE PATIENT SAMPLES WERE TESTED WITH THE RETENTION SAMPLE OF THE COMPLAINED LOT IN THE QUALITY CONTROL LABORATORY ACCORDING TO THE INSTRUCTIONS FOR USE. WE CONFIRMED THE FALSE POSITIVE REACTIONS OF THE CUSTOMER. THE CUSTOMER WAS AWARE OF THE FALSE POSITIVE REACTIONS BECAUSE HE TESTED THE SAMPLES WITH TWO DIFFERENT ANTI-K (KEL2) REAGENTS ACCORDING TO THE (B)(6) RULES "(B)(4)." THE AFFECTED LOT (B)(4) WAS FILLED OF THE BULK LOT 84707. A SECOND LOT, THE LOT (B)(4), WAS ALSO FILLED OF THE BULK LOT (B)(4). ALTHOUGH WE DID NOT RECEIVE ANY COMPLAINT FOR LOT (B)(4), THE BATCH WAS TESTED AND REACTED ALSO FALSE POSITIVE. ALBA BIOSCIENCE LIMITED, THE SUPPLIER OF THE BULK REAGENT SERACLONE ANTI-K (KEL2) WAS INFORMED AND CONFIRMED THE FALSE POSITIVE REACTIONS. AS A CONSEQUENCE OF THE CONFIRMED FALSE POSITIVE REACTIONS BOTH LOTS (B)(4) WERE BLOCKED AND A FIELD SAFETY CORRECTIVE ACTION WAS INITIATED. THE AFFECTED BATCHES ARE NOT ON THE U.S MARKET, AS THE MENTIONED CATALOG NUMBER IS USED FOR NON-US-PRODUCT ONLY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | SERACLONE ANTI-K (KEL2) | SERACLONE | KSZ | BIOTEST MEDICAL DIAGNOSTICS GMBH | 1847071 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |